A randomized, double‐blind, placebo‐controlled trial on the effect of long‐acting testosterone treatment as assessed by the Aging Male Symptoms scale

• Published in: BJU international Vol. 110; no. 2; pp. 260 - 265
• Main Authors: Ho, Christopher C.K., Tong, Seng Fah, Low, Wah Yun, Ng, Chirk Jenn, Khoo, Ee Ming, Lee, Verna K.M., Zainuddin, Zulkifli Md, Tan, Hui Meng
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.07.2012; Wiley-Blackwell
• Subjects: Adult; Aged; AMS scale; Analysis of Variance; Androgens - administration & dosage; Biological and medical sciences; Double-Blind Method; Humans; hypogonadism; Hypogonadism - drug therapy; injectable; Injections, Intramuscular; long‐acting; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; Quality of Life; Severity of Illness Index; Syndrome; Testosterone - administration & dosage; Testosterone - analogs & derivatives; Testosterone - deficiency; testosterone undecanoate; Long acting; Nephrology; Androgen; Evaluation scale; testosterone deficiency; Deficiency; Ageing; Slow release form; Male; testosterone undecanoate; Randomized controlled trial; Hypogonadism; Urology; Genital diseases; AMS scale; Symptomatology; Testosterone; injectable; Treatment; Double blind study; Testicular hormone; Sex steroid hormone; long-acting; Age
• ISSN: 1464-4096; 1464-410X; 1464-410X
• DOI: 10.1111/j.1464-410X.2011.10755.x

Study Type – Therapy (RCT) Level of Evidence 1b What's known on the subject? and What does the study add? Testosterone deficiency syndrome can be treated with testosterone replacement in the form of injectable, transdermal, buccal and oral preparations. Long‐acting i.m. testosterone undecanoate...